{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:55:36Z","timestamp":1778680536561,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Korean Health 21 R&D Project, Ministry of Health and Welfare"},{"name":"Samsung Medical Center Foundation for Medical Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0737-8","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:21:21Z","timestamp":1519964481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort"],"prefix":"10.1186","volume":"19","author":[{"given":"Hye Yun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suh-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Yong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Il","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Won","family":"Ra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Mok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don D.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Do","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Bum","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"737_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.chest.2015.08.017","volume":"149","author":"PJ Barnes","year":"2016","unstructured":"Barnes PJ. Asthma-COPD overlap. Chest. 2016;149:7\u20138.","journal-title":"Chest"},{"key":"737_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/COPD.S107307","volume":"11","author":"K Kostikas","year":"2016","unstructured":"Kostikas K, Clemens A, Patalano F. The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease? Int J Chron Obstruct Pulmon Dis. 2016;11:1297\u2013306.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"737_CR3","doi-asserted-by":"publisher","first-page":"e0136065","DOI":"10.1371\/journal.pone.0136065","volume":"10","author":"A Alshabanat","year":"2015","unstructured":"Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10:e0136065.","journal-title":"PLoS One"},{"key":"737_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1378\/chest.15-1055","volume":"149","author":"BG Cosio","year":"2016","unstructured":"Cosio BG, Soriano JB, Lopez-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149:45\u201352.","journal-title":"Chest"},{"key":"737_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/resp.12653","volume":"21","author":"NV Tho","year":"2016","unstructured":"Tho NV, Park HY, Nakano Y. Asthma-COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology. 2016;21:410\u20138.","journal-title":"Respirology"},{"key":"737_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1378\/chest.13-0622","volume":"145","author":"AM Menezes","year":"2014","unstructured":"Menezes AM, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297\u2013304.","journal-title":"Chest"},{"key":"737_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.arbres.2011.12.009","volume":"48","author":"JJ Soler-Cataluna","year":"2012","unstructured":"Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aguero R, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48:331\u20137.","journal-title":"Arch Bronconeumol"},{"key":"737_CR8","unstructured":"GINA. Global Strategy for Asthma Management and Prevention (2017 update). Available at http:\/\/ginasthma.org\/2017-gina-report-global-strategy-for-asthma-management-and-prevention\/ . Assessed 15 Sept 2017."},{"key":"737_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1183\/13993003.00436-2016","volume":"48","author":"DD Sin","year":"2016","unstructured":"Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48:664\u201373.","journal-title":"Eur Respir J"},{"key":"737_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1465-9921-12-127","volume":"12","author":"M Hardin","year":"2011","unstructured":"Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.","journal-title":"Respir Res"},{"key":"737_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.rmed.2013.03.007","volume":"107","author":"M Miravitlles","year":"2013","unstructured":"Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sanchez G, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107:1053\u201360.","journal-title":"Respir Med"},{"key":"737_CR12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1513\/AnnalsATS.201508-507OC","volume":"13","author":"M Sadatsafavi","year":"2016","unstructured":"Sadatsafavi M, Tavakoli H, Kendzerska T, Gershon A, To T, Aaron SD, et al. History of asthma in patients with chronic obstructive pulmonary disease. A comparative study of economic burden. Ann Am Thorac Soc. 2016;13:188\u201396.","journal-title":"Ann Am Thorac Soc"},{"key":"737_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejim.2016.06.020","volume":"34","author":"C Sorino","year":"2016","unstructured":"Sorino C, Pedone C, Scichilone N. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med. 2016;34:72\u20137.","journal-title":"Eur J Intern Med"},{"key":"737_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/resp.12556","volume":"20","author":"Y Yamauchi","year":"2015","unstructured":"Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, et al. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology. 2015;20:940\u20136.","journal-title":"Respirology"},{"key":"737_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S2213-2600(16)00098-9","volume":"4","author":"P Lange","year":"2016","unstructured":"Lange P, Colak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4:454\u201362.","journal-title":"Lancet Respir Med"},{"key":"737_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1183\/09031936.00008615","volume":"46","author":"R de Marco","year":"2015","unstructured":"de Marco R, Marcon A, Rossi A, Anto JM, Cerveri I, Gislason T, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015;46:671\u20139.","journal-title":"Eur Respir J"},{"key":"737_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000352053","volume":"87","author":"JJ Fu","year":"2014","unstructured":"Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87:63\u201374.","journal-title":"Respiration"},{"key":"737_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4046\/trd.2014.76.4.169","volume":"76","author":"TS Park","year":"2014","unstructured":"Park TS, Lee JS, Seo JB, Hong Y, Yoo JW, Kang BJ, et al. Study design and outcomes of Korean obstructive lung disease (KOLD) cohort study. Tuberc Respir Dis (Seoul). 2014;76:169\u201374.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"737_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"737_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4046\/trd.2005.58.3.230","volume":"58","author":"JK Choi","year":"2005","unstructured":"Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005;58:230\u201342.","journal-title":"Tuberc Respir Dis"},{"key":"737_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1513\/AnnalsATS.201501-005OC","volume":"12","author":"YM Oh","year":"2015","unstructured":"Oh YM, Jeong BH, Woo SY, Kim SY, Kim H, Lee JH, et al. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression. Ann Am Thorac Soc. 2015;12:1005\u201312.","journal-title":"Ann Am Thorac Soc."},{"key":"737_CR22","doi-asserted-by":"crossref","DOI":"10.1002\/9781119513469","volume-title":"Applied longitudinal analysis","author":"GM Fitzmaurice","year":"2011","unstructured":"Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd ed. Hoboken: Wiley; 2011.","edition":"2"},{"key":"737_CR23","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2147\/COPD.S114964","volume":"11","author":"SY Lee","year":"2016","unstructured":"Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, et al. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2797\u2013803.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"737_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","volume":"194","author":"M Suzuki","year":"2016","unstructured":"Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194:1358\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"737_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/COPD.S27480","volume":"7","author":"C Tantucci","year":"2012","unstructured":"Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"737_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/thorax.58.8.659","volume":"58","author":"PM Calverley","year":"2003","unstructured":"Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58:659\u201364.","journal-title":"Thorax"},{"key":"737_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/09031936.05.00102604","volume":"26","author":"NR Anthonisen","year":"2005","unstructured":"Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE, et al. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J. 2005;26:45\u201351.","journal-title":"Eur Respir J"},{"key":"737_CR28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184\u201392.","journal-title":"N Engl J Med"},{"key":"737_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3904\/kjim.2015.30.2.163","volume":"30","author":"KH Yoo","year":"2015","unstructured":"Yoo KH. Smoking cessation and chronic obstructive pulmonary disease. Korean J Intern Med. 2015;30:163\u20136.","journal-title":"Korean J Intern Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0737-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:36:59Z","timestamp":1660534619000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0737-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0737-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"6 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board of Asan Medical Center (no. 2005\u20130010). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give our consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.Y.P. has received lecture fees from AstraZeneca, Novartis and Boehringer-Ingelheim.D.D.S. is funded by the Canada Research Chair Program and has received honoraria for speaking engagements from Boehringer Ingelheim, AstraZenca, Regeneron and Sanofi Aventis over the past 18\u00a0months. He has also received research funding from BI, AZ and Merck during this time.None declared (S-Y.L., D.K., J.C., H.L., S.Y.L., H.I.Y., S.W.R., K.U.K., Y-M.O., S-D.L., Y.B.P.).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}